Immunic Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
26 Feb 24 | BuyUS$18,333 | Daniel Vitt | Individual | 14,000 | US$1.31 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 42,582 | 0.0473% |
Individual Insiders | 1,042,306 | 1.16% |
Institutions | 26,532,161 | 29.5% |
General Public | 27,200,893 | 30.2% |
Hedge Funds | 35,261,074 | 39.1% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 102.9%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
8,902,972 | US$10.9m | 0% | 0.43% | |||
8,902,972 | US$10.9m | 675% | 0.32% | |||
7,293,007 | US$8.9m | 2,330% | 0.89% | |||
6,993,007 | US$8.5m | 0% | no data | |||
5,594,406 | US$6.8m | 0% | 0.01% | |||
4,567,717 | US$5.6m | 5.36% | 0.09% | |||
3,394,047 | US$4.1m | 101% | no data | |||
2,162,782 | US$2.6m | 0% | 2.48% | |||
2,052,807 | US$2.5m | 5.74% | 0.12% | |||
1,974,571 | US$2.4m | 0% | 100.0% | |||
1,788,160 | US$2.2m | 0% | 1.62% | |||
1,612,378 | US$2.0m | 0% | 0.68% | |||
895,646 | US$1.1m | 114% | no data | |||
747,271 | US$911.7k | 899% | no data | |||
699,301 | US$853.1k | 0% | 0.09% | |||
661,254 | US$806.7k | 82.6% | no data | |||
423,522 | US$516.7k | 422% | 0.02% | |||
421,184 | US$513.8k | 0% | 0.07% | |||
376,877 | US$459.8k | 0% | no data | |||
321,749 | US$392.5k | 5.38% | no data | |||
272,457 | US$332.4k | 0% | 0.11% | |||
254,613 | US$310.6k | 119% | no data | |||
240,238 | US$293.1k | 46.1% | no data | |||
239,962 | US$292.8k | -57.1% | no data | |||
173,318 | US$211.5k | 17.6% | no data |